Crossref
ACTIVE-W Discontinued-Oral Anticoagulants Remain Treatment of Choice in Atrial Fibrillation
MD Conference Express · 2005
DOI: 10.1177/155989770501005 ↗Kurz gefasst
Fachartikel in der Zeitschrift MD Conference Express, 2005. Verfasst von S. Connolly.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Connolly, S. (2005). ACTIVE-W Discontinued-Oral Anticoagulants Remain Treatment of Choice in Atrial Fibrillation. MD Conference Express. https://doi.org/10.1177/155989770501005
Vancouver
Connolly S. ACTIVE-W Discontinued-Oral Anticoagulants Remain Treatment of Choice in Atrial Fibrillation. MD Conference Express. 2005. doi:10.1177/155989770501005
BibTeX
@article{Connolly2005,
author = {Connolly, S.},
title = {ACTIVE-W Discontinued-Oral Anticoagulants Remain Treatment of Choice in Atrial Fibrillation},
journal = {MD Conference Express},
year = {2005},
doi = {10.1177/155989770501005}
}
EUVIMED